Article
Comparison of commercial genetic-testing services in Korea with 23andMe service.
BioMed research international - 1 Jan 2014
Kim Sollip, Eom Ki-Won, Cho Chong-Rae, Um Tae Hyun
Abstract excerpt
INTRODUCTION: Genetic testing services for disease prediction, drug responses, and traits are commercially available by several companies in Korea. However, there has been no evaluation study for the accuracy and usefulness of these services. We aimed to compare two genetic testing services popular in Korea with 23andMe service in the United States. MATERIALS AND METHODS: We compared the results of two persons...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
